Amanote Research
Register
Sign In
Zinc Transporter HKE4 as a New Target in Antihormone Resistance of Breast Cancer
Breast Cancer Research
- United Kingdom
doi 10.1186/bcr1926
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
May 1, 2008
Authors
KM Taylor
N Jordan
S Hiscox
JM Gee
RI Nicholson
Publisher
Springer Science and Business Media LLC
Related search
Loss of PEDF: A Novel Mechanism of Antihormone Resistance in Breast Cancer
Obesity Hormone Leptin: A New Target in Breast Cancer?
Breast Cancer Research
Cancer Research
Oncology
Harnessing Drug Resistance: Using ABC Transporter Proteins to Target Cancer Cells
Biochemical Pharmacology
Biochemistry
Pharmacology
Revisiting the IGF-1R as a Breast Cancer Target
npj Precision Oncology
Tissue Transglutaminase: A New Target to Reverse Cancer Drug Resistance
Amino Acids
Organic Chemistry
Biochemistry
Clinical Biochemistry
Tissue Factor as a New Target for CAR-NK Cell Immunotherapy of Triple-Negative Breast Cancer
Scientific Reports
Multidisciplinary
Structure-Function Analysis of HKE4, a Member of the New LIV-1 Subfamily of Zinc Transporters
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
Lewis Y Antigen as a Target for Breast Cancer Therapy